VC Fund Dossiers

3VC is the disciplined European operator you want when the market gets frothy. While other funds were throwing money at inflated rounds in 2021, they stayed selective with their 3-4 deals per year strategy. This 'quality over quantity' approach paid off with 3 unicorns from just 12 Fund I companies - that's a 25% unicorn rate that would make Sequoia jealous. The team genuinely gets product-market fit (Eva's IoT background shows) and isn't afraid to get their hands dirty - they literally structured Gamee's acquisition by Animoca Brands during tough times. The downside? They're picky as hell and take forever to decide, plus their DACH/CEE focus means they might miss broader European trends.

Nathan Benaich is the rare VC who actually knows what he's talking about technically - his PhD in cancer biology and decade of State of AI Reports mean he spots trends before other VCs even know they exist. As Europe's largest solo GP fund with $232M, he can move fast with single decision-maker speed and write meaningful checks. The guy is obsessed with "AI-first" companies where removing the AI kills the product entirely, which filters out a lot of AI-washing. He's particularly interested in European defense capabilities and wants founders with maniacal focus combined with humility. The downside? Europe still has a thinner pipeline of globally scalable AI companies compared to North America, so you're betting on that gap closing. But if you're building something truly AI-native in biotech, robotics, or defense, few investors will understand your technology better or move faster.

Alexia is one of the more credible Series A shops in Brazil, built by operators who actually understand both Silicon Valley and LatAm markets. Patrick's 25-year track record spanning both regions gives them real deal sourcing advantage, while Bianca's Endeavor pedigree means she knows how to spot and develop global-caliber founders. They're betting big on the thesis that Latin American talent can build world-class companies – and their portfolio suggests they're right. The fund's emphasis on 'intellectual honesty' and fast-tracking junior talent shows they're thinking long-term about relationship building, not just financial returns. Watch for their ability to help portfolio companies scale internationally.

ANRI is one of Japan's most successful seed funds with genuine returns to back up the hype - their first fund hit 20x returns, which is legitimately impressive. The team is surprisingly progressive for Japan VC, committing to 20% women entrepreneur targets and actually hitting it, plus they run quality programs like STARTLINE and CIRCLE that show real founder-first thinking. Samata clearly has operator chops from his FreakOut/Recruit days and recently completed Stanford's executive program, showing he's still learning. But here's the thing - they're still very Japan-focused despite global ambitions, and while they talk about 'extraordinary futures,' most of their wins are solid but not groundbreaking consumer/enterprise plays. They do solid seed checks ($1-3M) and seem genuinely helpful post-investment, but don't expect Silicon Valley-style risk appetite or global network effects.

APEX Ventures is the rare European deep tech fund that actually understands what they're investing in - probably because their partners have real operational experience rather than just finance backgrounds. Andreas Riegler built and sold companies before becoming a VC, Wolfgang Neubert has deep technical expertise in photonics and quantum, and Gordon Euller is a practicing radiologist who worked at McKinsey. This translates into genuine value-add for founders wrestling with complex IP strategies and brutal commercialization timelines. The €80M Amadeus APEX Technology Fund partnership gives them serious firepower, and their portfolio companies consistently praise their hands-on support and network introductions. However, they're primarily focused on DACH region deals, so if you're not in Germany/Austria/Switzerland, you might be swimming upstream. Also, while they talk a good game about being 'founder-friendly,' deep tech investors by nature tend to want more control given the long development cycles and capital intensity.

Ascendo is the rare Korean fund that actually gets cross-border expansion - their partners have been there and done that with Formation 8, SoftBank Ventures, and Toss. Aaron's Formation 8 pedigree and Jason's early bet on Toss show they can spot unicorns before they become unicorns. They've got two successful IPOs in their portfolio (ROKIT Healthcare and LIVSMED), which is impressive for a relatively young fund. But here's the catch - their current fund is focused on climate and environmental sectors, so they couldn't even follow-on in their own successful AI portfolio company Medipixel's Series B. That's either incredibly disciplined or incredibly frustrating, depending on your perspective.

Top 3 management firms in Brazil preferred by entrepreneurs, according to a survey by Spectra. Here at Astella, if we take our 9 funds under management (active and inactive; portfolio and dedicated) we would have an aggregate IRR of 44% per year. Overall, Astella portfolio has seen 1 unicorn and 12 acquisitions including key companies like HealthHelp, Omie and RD Station. The fund has a solid track record with major exits like RD Station's sale to TOTVS, though they're not flashy about it. Laura Constantini is legitimately a pioneer as one of the first female VCs in LatAm, and the team brings real operational experience rather than just finance backgrounds. They're knowledge-obsessed with their "Matrix" content hub and genuinely seem to add value beyond just capital. Watch for their focus on 'value investors in VC' - they're not chasing unicorns at any price.

Bee Partners is a solid, no-nonsense B2B fund that actually knows what they're talking about when it comes to marketplaces and fintech. Michael Berolzheimer has real operational chops and won't waste your time with fluffy feedback — he'll tell you exactly what's broken and how to fix it. The downside? He can be pretty intense and some founders find him overwhelming. They're not the biggest check writers, but they punch above their weight on portfolio support and have genuine expertise in their sectors. If you're building a B2B marketplace or fintech tool, they're worth the meeting.

Beyond Ventures is Hong Kong's most visible local VC success story, and they've got the trophy portfolio to prove it - four IPOs including SenseTime and Prenetics is legitimately impressive for a 2017 vintage fund. Lap Man and the team clearly have strong networks in both Hong Kong's research ecosystem and mainland China's growth markets, which explains their ability to spot winners like SenseTime early. However, this is very much a Hong Kong-centric fund with a 'From Hong Kong, For Hong Kong' mentality - great if you're building for Greater China markets, but they may not be your best bet if you're thinking global-first. The partners bring real operational experience (Lap Man built and exited DYXnet, Alex Fang has 18 years TMT experience), but founders should expect a fairly traditional Asian VC approach rather than Silicon Valley-style hustle.

This is Bangkok Bank's CVC arm playing it safe and strategic — they're not chasing unicorns, they're building an ecosystem that feeds business back to the mothership. It is a wholly owned subsidiary of Bangkok Bank and their investments are clearly designed to create synergies with the bank's customer base. The good: they have deep pockets, patient capital, and genuine value-add through Bangkok Bank's massive SME network. The reality check: this isn't a pure VC play — expect slower decisions, more bureaucracy, and investments that need to make sense for the bank's broader strategy. Their portfolio has seen 1 unicorn, namely LINE MAN Wongnai, but most investments are B2B tools that help digitize traditional Thai businesses.

Song Eun-kang has built a solid reputation as Korea's 'guardian angel' for early-stage companies, with legendary wins like 20x returns on Danggeun Market (Karrot) - they got in below 10 billion won valuation and it's now worth 3 trillion won. The fund punches above its 200 billion won (~$168M) AUM with 3 unicorns in portfolio including FADU, Kurly, and Sendbird. Song focuses heavily on execution ability and team collaboration over flashy pitches, which explains their early bets on overlooked winners. However, their social media presence is nearly nonexistent and they're very Korea-focused - don't expect much hand-holding on global expansion or Silicon Valley-style brand building.

This is one of the few funds where the "operator-led" marketing actually matches reality. The three founding partners genuinely built massive hardware businesses (Flex went from $150M to $30B under their watch), so when they say they'll roll up sleeves, they mean it. The US-India corridor focus is prescient timing as geopolitical winds shift manufacturing. However, be prepared for very hands-on investors who will want deep involvement in operational decisions - this cuts both ways depending on your tolerance for strong opinions from experienced operators. Their portfolio has genuine technical depth (semiconductors, AI infrastructure, space tech) rather than just buzzword bingo, and the exits speak for themselves with IPOs like Robinhood and Credo. The downside? These guys have run $25B+ companies, so if you're looking for patient capital while you figure things out, this might not be your crowd.

This is the rare VC who actually writes the first check - Matt was literally Hims & Hers' first investor when it was 'merely an idea,' investing 10 months before any other external investor joined the cap table. Founders consistently describe Matt as a 'powerful force of positive energy' who's 'endlessly optimistic' and 'joyful,' with one partner noting his optimism is genuinely contagious. The relationship depth is real - founders like Andrew Dudum call Matt 'brother' after years of partnership that goes beyond just business. As one of the world's first and largest Solo GP funds, Matt has unprecedented decision-making speed, but this also means if he doesn't personally click with you, there's no Plan B. The track record speaks for itself with 12+ unicorns, but founders should know they're getting a tennis player's competitive intensity wrapped in genuine warmth.

Conviction is the real deal - Sarah and Elad both have stellar reputations and genuinely know how to build software companies. They're not just check writers; they roll up their sleeves on product strategy, hiring, and go-to-market. The catch? They're extremely selective and have very high bars for traction and team quality. If you get them interested, you're probably onto something big, but don't expect them to take flyers on unproven concepts. They also move fast when they want to invest, so be ready.

Copper Sky is one of the more legitimate regional funds that actually adds value beyond just writing checks. They've had some solid wins like ServiceTitan and genuinely understand B2B software. The Phoenix angle isn't just marketing - they do find good deals that coastal VCs miss. That said, their network outside the Southwest can be limited, so if you need heavy Silicon Valley connections for later rounds, factor that in. Partners are generally founder-friendly and won't micromanage, but they're not afraid to have tough conversations when needed.

This is the rare fund where the 'former Microsoft AI operators' tagline isn't just marketing fluff - Chang and Harris actually built speech and NLP tech at Microsoft before becoming VCs. They lead rounds fast and help founders syndicate quickly so they can get back to building, with a hands-on approach that adapts to whatever each company needs rather than following a rigid playbook. Portfolio companies genuinely praise their AI/ML expertise and 'roll-up-their-sleeves approach,' plus their commitment to diversity. They've expanded beyond their Pacific Northwest roots after proving their thesis, now seeing deal flow across the U.S. and Canada. The risk? They're still relatively small with limited dry powder compared to the AI funding arms race, and their sweet spot may be getting squeezed as seed rounds inflate.